Your browser doesn't support javascript.
loading
Adjuvant radiation therapy improves survival in stage IIIA (N2) non-small cell lung cancer with persistent N2 disease after neoadjuvant chemotherapy.
Komiya, Takefumi; Takamori, Shinkichi; Wilding, Gregory.
Affiliation
  • Komiya T; Division of Hematology Oncology, University at Buffalo, 100 High St D2-76, Buffalo, NY 14203, United States. Electronic address: takefumi@buffalo.edu.
  • Takamori S; Department of Surgery and Science, Kyushu University, Fukuoka, Japan.
  • Wilding G; Department of Biostatistics, School of Public Health and Health Professions, University at Buffalo, United States.
Radiother Oncol ; 176: 234-238, 2022 11.
Article in En | MEDLINE | ID: mdl-36192229
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Radiother Oncol Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Radiother Oncol Year: 2022 Document type: Article Country of publication: